 |
市場調查報告書
商品編碼
1098609
低分子注射劑的市場規模、佔有率、展望、機會 (2022年～2030年):各藥物類別、適應症、投藥方式、終端用戶、地區Small Molecule Injectable Drugs Market, by Drug Class, by Indication, by Mode of Delivery, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 |
||||||
價格
簡介目錄
在進入經營者的新製造設施開始生產注射藥物，及新的低分子注射劑取得法規當局的認證等要素預計促進在預測期間內的全球低分子注射劑市場成長。
本報告提供全球低分子注射劑的市場調查，市場定義和概要，市場成長的各種影響因素分析，法律制度，市場規模的變化、預測，各種區分、各地區/主要國家的明細，競爭環境，主要企業簡介等彙整資訊。
目錄
第1章 調查目的、前提條件
第2章 市場概要
第3章 市場動態、法規、趨勢分析
- 市場動態
- 促進因素
- 阻礙因素
- 市場機會
- 影響分析
- 法規情境
- PEST分析
- 最近的產品銷售/核准
- 流行病學
- M&A
第4章 全球低分子注射劑市場:COVID-19影響
- 供應鏈的影響
- R&D的影響
- 政府的舉措
第5章 全球低分子注射劑市場:各類藥物
- 化療
- 低分子抗生素
- 骨骼肌肉鬆弛劑
- 止痛藥
- 抗凝固劑
- 抗痙攣藥
- 抗病毒藥物
- 其他
第6章 全球低分子注射劑市場:各適應症
- 腫瘤
- 疼痛管理
- 心血管疾病
- 感染疾病
- 中樞神經系統疾病
- 其他
第7章 全球低分子注射劑市場:各投藥模式
- IV設備
- 輸液幫浦
- 靜脈注射
- 肌肉內注射
- 皮下注射
第8章 全球低分子注射劑市場:各終端用戶
- 醫院
- 門診病人診所
- 門診設施
- 點滴療法中心
- 居家照護
- 其他
第9章 全球低分子注射劑市場:各地區
- 北美
- 南美
- 歐洲
- 亞太地區
- 中東
- 非洲
第10章 競爭情形
- 企業簡介
- Novartis AG
- Pfizer, Inc.
- Sun Pharmaceutical Industries Ltd.
- Merck &Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- Aurobindo Pharma Ltd.
- AstraZeneca Plc
- Baxter International Inc.
- Fresenius Kabi AG
- Cipla Limited.
- Mylan NV
- GlaxoSmithKline Plc.
- Johnson &Johnson
- Sanofi SA
- Reddy's Laboratories Ltd.
- Hoffmann-La Roche AG(Genentech, Inc.)
- Amgen, Inc.
- Gilead Sciences, Inc.
- Hikma Pharmaceuticals plc
- 分析師的見解
第11章 Section
簡介目錄
Product Code: CMI5033
The term 'small molecule' or low-molecular-weight organic compound means that the drug can be administered orally or that it can be injected through parenteral routes. Small-molecule injectable drugs are used in the treatment of oncology disorders, infectious diseases, blood diseases, and cardiovascular diseases.
Moreover, the small-molecule drugs are very easy to synthesize and can be produced in large quantities and also these drugs are very simple to manufacture, which leads to strong generic competition among market players. As small molecules typically work by mimicking biological substrates or allosterically targeting hydrophobic pockets of proteins, certain biological targets may not be druggable. Many bacterial and cancer cells have developed resistance to small-molecule drugs through mechanisms such as chemoenzymatic modifications, efflux pumps, drug target mutations, etc.
Market Dynamics
Market players are initiating production of injectable drugs in the new manufacturing facility, which is expected to drive growth of the global small molecule injectable drugs, over the forecast period. For instance, in August 2018, Pfizer Inc., a pharmaceutical and Biotechnology Corporation, announced injectable production at Portage in Kalamazoo, Michigan. The plant will enable Pfizer to produce injectable medicines for patients suffering from chronic diseases such as oncology, across the globe, as well as supporting the company's supply capacity and production.
Key players are involved in receiving approvals from regulatory authorities for new small molecule injectable drugs. This is expected to drive growth of the global small molecule injectable drugs market, over the forecast period. For instance in October 2020, Aurobindo Pharma Ltd., a pharmaceutical company, announced that they received approval from the U.S. Food and Drug Administration for its generic acetaminophen injection. It is indicated for the treatment of pain in pediatric patients and adults.
Moreover, in 2018, Aurobindo Pharma Ltd. announced that they received approval from U.S. Food and Drug Administration to manufacture and market Vecuronium Bromide Injection, 10mg and 20mg for the U.S. markets. This drug is utilized as a part of general anesthesia to give skeletal muscle relaxation during mechanical ventilation or surgery.
Key features of the study:
- This report provides an in-depth analysis of the global small molecule injectable drugs market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global small molecule injectable drugs market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include Novartis AG, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd. AstraZeneca Plc, Baxter International Inc., Fresenius Kabi AG, Cipla Limited., Mylan N.V., GlaxoSmithKline Plc., Johnson & Johnson, Sanofi S.A., Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche AG (Genentech, Inc.), Amgen, Inc., Gilead Sciences, Inc., and Hikma Pharmaceuticals plc
- Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global small molecule injectable drugs market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global small molecule injectable drugs market
Detailed Segmentation:
- Global Small Molecule Injectable Drugs Market, By Drug Class:
- Chemotherapy
- Small Molecule Antibiotics
- Skeletal Muscle Relaxants
- Analgesics
- Anticoagulants
- Anticonvulsants
- Antivirals
- Others
- Global Small Molecule Injectable Drugs Market, By Indication:
- Oncology
- Pain Management
- Cardiovascular Diseases
- Infectious Diseases
- CNS Diseases
- Others
- Global Small Molecule Injectable Drugs Market, By Mode of Delivery:
- IV Set
- Infusion Pump
- Intravenous Injection
- Intramuscular Injection
- Subcutaneous Injection
- Global Small Molecule Injectable Drugs Market, By End User:
- Hospitals
- Ambulatory Clinics
- Outpatient Facility
- Infusion Therapy Center
- Home Care
- Others
- Global Small Molecule Injectable Drugs Market, By Region:
- North America
- By Country:
- U.S.
- Canada
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- North America
- Company Profiles
- Novartis AG *
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Pfizer, Inc.
- Sun Pharmaceutical Industries Ltd.
- Merck & Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- Aurobindo Pharma Ltd.
- AstraZeneca Plc
- Baxter International Inc.
- Fresenius Kabi AG
- Cipla Limited.
- Mylan N.V.
- GlaxoSmithKline Plc.
- Johnson & Johnson
- Sanofi S.A.
- Reddy's Laboratories Ltd.
- Hoffmann-La Roche AG (Genentech, Inc.)
- Amgen, Inc.
- Gilead Sciences, Inc.
- Hikma Pharmaceuticals plc
- Novartis AG *
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Indication
- Market Snippet, By Mode Of Delivery
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Regulatory Scenario
- PEST Analysis
- Recent Product Launch/Approval
- Epidemiology
- Mergers and Acquisitions
4. Global Small Molecule Injectable Drugs Market - Impact of Coronavirus (Covid-19) Pandemic
- Impact on Supply Chain
- Impact on Research and Development
- Government Initiatives
5. Global Small Molecule Injectable Drugs Market, By Drug Class, 2017-2030 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Small Molecule Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Skeletal Muscle Relaxants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Anticoagulants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Anticonvulsants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Antivirals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
6. Global Small Molecule Injectable Drugs Market, By Indication, 2017 - 2030 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- CNS Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
7. Global Small Molecule Injectable Drugs Market, By Mode of Delivery, 2017 - 2030 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- IV Set
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Infusion Pump
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Intravenous Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Intramuscular Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Subcutaneous Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
8. Global Small Molecule Injectable Drugs Market, By End User, 2017 - 2030 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Ambulatory Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Outpatient Facility
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Infusion Therapy Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Home Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
9. Global Small Molecule Injectable Drugs Market, By Region, 2017 - 2030 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018 - 2030
- Regional Trends
- North America
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Mode of Delivery, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Mode of Delivery, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Mode of Delivery, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Mode of Delivery, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Mode of Delivery, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Mode of Delivery, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
- South Africa
- Central Africa
- North Africa
10. Competitive Landscape
- Company Profiles
- Novartis AG
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Pfizer, Inc.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Merck & Co., Inc.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Aurobindo Pharma Ltd.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- AstraZeneca Plc
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Baxter International Inc.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Fresenius Kabi AG
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Cipla Limited.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Mylan N.V.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- GlaxoSmithKline Plc.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Johnson & Johnson
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Sanofi S.A.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Reddy's Laboratories Ltd.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Hoffmann-La Roche AG (Genentech, Inc.)
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Amgen, Inc.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Gilead Sciences, Inc.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Hikma Pharmaceuticals plc
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Analyst Views
11. Section
- References
- Research Methodology
- About us and Sales Contact
